Mr. Luo Yitian is the current managing director of Yunfeng Capital. He is responsible for the investment and management in the field of health care. Prior to joining Yunfeng, he worked for Decheng Capital and Bay City Capital, a biomedical specialty fund. Yitian is focused on investment opportunities in biotechnology and pharmaceutical health in China and the United States. Previously, he was the co-founder of Meritco-Services, the fifth largest management consulting firm in China currently. Yitian was in charge of consulting and management in the medical field. Prior to that, Yitian served as a management consultant for McKinsey & Company.